 | • レポートコード：MRC2-11QY04478 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は変形性関節症再生治療のグローバル市場について調査・分析したレポートです。種類別（細胞療法、組織工学、遺伝子治療）市場規模、用途別（病院、外来外科センター、整形外科クリニック、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別変形性関節症再生治療の競争状況、市場シェア ・世界の変形性関節症再生治療市場：種類別市場規模 2015年-2020年（細胞療法、組織工学、遺伝子治療） ・世界の変形性関節症再生治療市場：種類別市場規模予測 2021年-2026年（細胞療法、組織工学、遺伝子治療） ・世界の変形性関節症再生治療市場：用途別市場規模 2015年-2020年（病院、外来外科センター、整形外科クリニック、研究所） ・世界の変形性関節症再生治療市場：用途別市場規模予測 2021年-2026年（病院、外来外科センター、整形外科クリニック、研究所） ・北米の変形性関節症再生治療市場分析：米国、カナダ ・ヨーロッパの変形性関節症再生治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの変形性関節症再生治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の変形性関節症再生治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの変形性関節症再生治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Acelity、Mesoblast、Nuo Therapeutics、Astellas Pharma、Organovo、Orgenesis、Sanofi、Athersys、Takeda、Cytori Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone.
The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market.
Market Analysis and Insights: Global Regenerative Therapies for Osteoarthritis Market
The global Regenerative Therapies for Osteoarthritis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Regenerative Therapies for Osteoarthritis Scope and Market Size
Regenerative Therapies for Osteoarthritis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Regenerative Therapies for Osteoarthritis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Acelity
Mesoblast
Nuo Therapeutics
Astellas Pharma
Organovo
Orgenesis
Sanofi
Athersys
Takeda
Cytori Therapeutics
Market segment by Type, the product can be split into
Cell Therapy
Tissue Engineering
Gene Therapy
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Orthopaedic Clinics
Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Regenerative Therapies for Osteoarthritis Revenue
1.4 Market by Type
1.4.1 Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cell Therapy
1.4.3 Tissue Engineering
1.4.4 Gene Therapy
1.5 Market by Application
1.5.1 Global Regenerative Therapies for Osteoarthritis Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Orthopaedic Clinics
1.5.5 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Therapies for Osteoarthritis Market Perspective (2015-2026)
2.2 Global Regenerative Therapies for Osteoarthritis Growth Trends by Regions
2.2.1 Regenerative Therapies for Osteoarthritis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Regenerative Therapies for Osteoarthritis Historic Market Share by Regions (2015-2020)
2.2.3 Regenerative Therapies for Osteoarthritis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Regenerative Therapies for Osteoarthritis Market Growth Strategy
2.3.6 Primary Interviews with Key Regenerative Therapies for Osteoarthritis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Therapies for Osteoarthritis Players by Market Size
3.1.1 Global Top Regenerative Therapies for Osteoarthritis Players by Revenue (2015-2020)
3.1.2 Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Players (2015-2020)
3.1.3 Global Regenerative Therapies for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Regenerative Therapies for Osteoarthritis Market Concentration Ratio
3.2.1 Global Regenerative Therapies for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Regenerative Therapies for Osteoarthritis Revenue in 2019
3.3 Regenerative Therapies for Osteoarthritis Key Players Head office and Area Served
3.4 Key Players Regenerative Therapies for Osteoarthritis Product Solution and Service
3.5 Date of Enter into Regenerative Therapies for Osteoarthritis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Regenerative Therapies for Osteoarthritis Historic Market Size by Type (2015-2020)
4.2 Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020)
5.2 Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Regenerative Therapies for Osteoarthritis Market Size (2015-2020)
6.2 Regenerative Therapies for Osteoarthritis Key Players in North America (2019-2020)
6.3 North America Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020)
6.4 North America Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Regenerative Therapies for Osteoarthritis Market Size (2015-2020)
7.2 Regenerative Therapies for Osteoarthritis Key Players in Europe (2019-2020)
7.3 Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020)
7.4 Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020)
8 China
8.1 China Regenerative Therapies for Osteoarthritis Market Size (2015-2020)
8.2 Regenerative Therapies for Osteoarthritis Key Players in China (2019-2020)
8.3 China Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020)
8.4 China Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Regenerative Therapies for Osteoarthritis Market Size (2015-2020)
9.2 Regenerative Therapies for Osteoarthritis Key Players in Japan (2019-2020)
9.3 Japan Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020)
9.4 Japan Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Regenerative Therapies for Osteoarthritis Market Size (2015-2020)
10.2 Regenerative Therapies for Osteoarthritis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020)
10.4 Southeast Asia Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020)
11 India
11.1 India Regenerative Therapies for Osteoarthritis Market Size (2015-2020)
11.2 Regenerative Therapies for Osteoarthritis Key Players in India (2019-2020)
11.3 India Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020)
11.4 India Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Regenerative Therapies for Osteoarthritis Market Size (2015-2020)
12.2 Regenerative Therapies for Osteoarthritis Key Players in Central & South America (2019-2020)
12.3 Central & South America Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020)
12.4 Central & South America Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Acelity
13.1.1 Acelity Company Details
13.1.2 Acelity Business Overview
13.1.3 Acelity Regenerative Therapies for Osteoarthritis Introduction
13.1.4 Acelity Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020))
13.1.5 Acelity Recent Development
13.2 Mesoblast
13.2.1 Mesoblast Company Details
13.2.2 Mesoblast Business Overview
13.2.3 Mesoblast Regenerative Therapies for Osteoarthritis Introduction
13.2.4 Mesoblast Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020)
13.2.5 Mesoblast Recent Development
13.3 Nuo Therapeutics
13.3.1 Nuo Therapeutics Company Details
13.3.2 Nuo Therapeutics Business Overview
13.3.3 Nuo Therapeutics Regenerative Therapies for Osteoarthritis Introduction
13.3.4 Nuo Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020)
13.3.5 Nuo Therapeutics Recent Development
13.4 Astellas Pharma
13.4.1 Astellas Pharma Company Details
13.4.2 Astellas Pharma Business Overview
13.4.3 Astellas Pharma Regenerative Therapies for Osteoarthritis Introduction
13.4.4 Astellas Pharma Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020)
13.4.5 Astellas Pharma Recent Development
13.5 Organovo
13.5.1 Organovo Company Details
13.5.2 Organovo Business Overview
13.5.3 Organovo Regenerative Therapies for Osteoarthritis Introduction
13.5.4 Organovo Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020)
13.5.5 Organovo Recent Development
13.6 Orgenesis
13.6.1 Orgenesis Company Details
13.6.2 Orgenesis Business Overview
13.6.3 Orgenesis Regenerative Therapies for Osteoarthritis Introduction
13.6.4 Orgenesis Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020)
13.6.5 Orgenesis Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Regenerative Therapies for Osteoarthritis Introduction
13.7.4 Sanofi Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Athersys
13.8.1 Athersys Company Details
13.8.2 Athersys Business Overview
13.8.3 Athersys Regenerative Therapies for Osteoarthritis Introduction
13.8.4 Athersys Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020)
13.8.5 Athersys Recent Development
13.9 Takeda
13.9.1 Takeda Company Details
13.9.2 Takeda Business Overview
13.9.3 Takeda Regenerative Therapies for Osteoarthritis Introduction
13.9.4 Takeda Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020)
13.9.5 Takeda Recent Development
13.10 Cytori Therapeutics
13.10.1 Cytori Therapeutics Company Details
13.10.2 Cytori Therapeutics Business Overview
13.10.3 Cytori Therapeutics Regenerative Therapies for Osteoarthritis Introduction
13.10.4 Cytori Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020)
13.10.5 Cytori Therapeutics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Regenerative Therapies for Osteoarthritis Key Market Segments
Table 2. Key Players Covered: Ranking by Regenerative Therapies for Osteoarthritis Revenue
Table 3. Ranking of Global Top Regenerative Therapies for Osteoarthritis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cell Therapy
Table 6. Key Players of Tissue Engineering
Table 7. Key Players of Gene Therapy
Table 8. Global Regenerative Therapies for Osteoarthritis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Regenerative Therapies for Osteoarthritis Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Regenerative Therapies for Osteoarthritis Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Regenerative Therapies for Osteoarthritis Market Share by Regions (2015-2020)
Table 12. Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Regenerative Therapies for Osteoarthritis Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Regenerative Therapies for Osteoarthritis Market Growth Strategy
Table 18. Main Points Interviewed from Key Regenerative Therapies for Osteoarthritis Players
Table 19. Global Regenerative Therapies for Osteoarthritis Revenue by Players (2015-2020) (Million US$)
Table 20. Global Regenerative Therapies for Osteoarthritis Market Share by Players (2015-2020)
Table 21. Global Top Regenerative Therapies for Osteoarthritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Therapies for Osteoarthritis as of 2019)
Table 22. Global Regenerative Therapies for Osteoarthritis by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Regenerative Therapies for Osteoarthritis Product Solution and Service
Table 25. Date of Enter into Regenerative Therapies for Osteoarthritis Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$)
Table 28. Global Regenerative Therapies for Osteoarthritis Market Size Share by Type (2015-2020)
Table 29. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2021-2026)
Table 30. Global Regenerative Therapies for Osteoarthritis Market Size Share by Application (2015-2020)
Table 31. Global Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$)
Table 32. Global Regenerative Therapies for Osteoarthritis Market Size Share by Application (2021-2026)
Table 33. North America Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020)
Table 35. North America Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$)
Table 36. North America Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020)
Table 37. North America Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$)
Table 38. North America Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020)
Table 39. Europe Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020)
Table 41. Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020)
Table 43. Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020)
Table 45. China Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$)
Table 46. China Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020)
Table 47. China Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$)
Table 48. China Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020)
Table 49. China Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$)
Table 50. China Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020)
Table 51. Japan Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020)
Table 53. Japan Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020)
Table 55. Japan Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020)
Table 59. Southeast Asia Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020)
Table 61. Southeast Asia Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020)
Table 63. India Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$)
Table 64. India Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020)
Table 65. India Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$)
Table 66. India Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020)
Table 67. India Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$)
Table 68. India Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020)
Table 71. Central & South America Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020)
Table 73. Central & South America Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020)
Table 75. Acelity Company Details
Table 76. Acelity Business Overview
Table 77. Acelity Product
Table 78. Acelity Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$)
Table 79. Acelity Recent Development
Table 80. Mesoblast Company Details
Table 81. Mesoblast Business Overview
Table 82. Mesoblast Product
Table 83. Mesoblast Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$)
Table 84. Mesoblast Recent Development
Table 85. Nuo Therapeutics Company Details
Table 86. Nuo Therapeutics Business Overview
Table 87. Nuo Therapeutics Product
Table 88. Nuo Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$)
Table 89. Nuo Therapeutics Recent Development
Table 90. Astellas Pharma Company Details
Table 91. Astellas Pharma Business Overview
Table 92. Astellas Pharma Product
Table 93. Astellas Pharma Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$)
Table 94. Astellas Pharma Recent Development
Table 95. Organovo Company Details
Table 96. Organovo Business Overview
Table 97. Organovo Product
Table 98. Organovo Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$)
Table 99. Organovo Recent Development
Table 100. Orgenesis Company Details
Table 101. Orgenesis Business Overview
Table 102. Orgenesis Product
Table 103. Orgenesis Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$)
Table 104. Orgenesis Recent Development
Table 105. Sanofi Company Details
Table 106. Sanofi Business Overview
Table 107. Sanofi Product
Table 108. Sanofi Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$)
Table 109. Sanofi Recent Development
Table 110. Athersys Business Overview
Table 111. Athersys Product
Table 112. Athersys Company Details
Table 113. Athersys Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$)
Table 114. Athersys Recent Development
Table 115. Takeda Company Details
Table 116. Takeda Business Overview
Table 117. Takeda Product
Table 118. Takeda Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$)
Table 119. Takeda Recent Development
Table 120. Cytori Therapeutics Company Details
Table 121. Cytori Therapeutics Business Overview
Table 122. Cytori Therapeutics Product
Table 123. Cytori Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$)
Table 124. Cytori Therapeutics Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Regenerative Therapies for Osteoarthritis Market Share by Type: 2020 VS 2026
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Gene Therapy Features
Figure 5. Global Regenerative Therapies for Osteoarthritis Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Orthopaedic Clinics Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Regenerative Therapies for Osteoarthritis Report Years Considered
Figure 11. Global Regenerative Therapies for Osteoarthritis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Regenerative Therapies for Osteoarthritis Market Share by Regions: 2020 VS 2026
Figure 13. Global Regenerative Therapies for Osteoarthritis Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Regenerative Therapies for Osteoarthritis Market Share by Players in 2019
Figure 16. Global Top Regenerative Therapies for Osteoarthritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Therapies for Osteoarthritis as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Regenerative Therapies for Osteoarthritis Revenue in 2019
Figure 18. North America Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
再生医療の世界市場（～2026年） Regeneration is renewal through the internal processes of a body or system. Something which embodies this action can be described as regenerative. The global market study on regenerative therapies is expected to grow rapidly owing to its wide applications in orthopedic, cardiovascular and soft tissu…- 変形性関節症における幹細胞治療の世界市場（～2026年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…
- 精密がん治療の世界市場（～2026年） Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormali…
- 変形性関節症治療の世界市場（～2026年） Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swellin…
- がん治療の世界市場（～2026年） Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer,…